Omega Healthcare (WX4) AI Stock Analysis

Company Guidance

The company increased and tightened its full year adjusted FFO guidance to a range of $3.28 to $3.30 per share from $3.22 to $3.26 per share, with a midpoint of $3.29 per share, a $0.05 increase over the midpoint of July guidance, and a $0.19 increase over 2025 full year AFFO of $3.10, representing a 6% year over year increase in AFFO while paying out a dividend yield of nearly 6%; guidance includes $946 million of new investments completed since quarter end, including the $846 million foundation mortgage loan, the PACS transition’s $26.1 million increase in annual contractual rent and 33.8 million in annual straight line revenue in the first year, no additional operators placed on a cash basis, NewGen’s full contractual rent of $13.3 million per quarter and approximately $14 million in straight line revenue per quarter, Maplewood monthly rent of $6.9 million, repayment in Q4 of $306 million of loans outstanding at September 30, 2026, including $150 million of Genesis loans, $15 million to $25 million in asset sales each quarter, quarterly G&A expense of approximately $14 million to $15.5 million, and the $0.0608 per share dividend; the high end of the guidance range includes is not limited to, additional payments from cash basis operators, exposure to the operating portfolio through RIDEA and JV investments, and G&A at the lower end of the range.